MSCs from MRL.Faslpr mice and lupus patients exhibited reduced B cell–suppressive activity both in vivo and in vitro because of a decreased production of CCL2 and its antagonistic variant compared to control MSCs25. Here, CCL2 is linked to systemic lupus erythematosus.